| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absence and presence: the potential for art to facilitate improved communication about pain
|
Padfield, Deborah
|
|
|
7 |
2 |
p. e96-e97
|
article
|
| 2 |
Acalabrutinib monotherapy in patients with Waldenström macroglobulinemia: a single-arm, multicentre, phase 2 study
|
Owen, Roger G
|
|
|
7 |
2 |
p. e112-e121
|
article
|
| 3 |
Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial
|
Walker, Irwin
|
|
|
7 |
2 |
p. e100-e111
|
article
|
| 4 |
Alisertib: a new option for acute myeloid leukaemia
|
Thomas, Xavier
|
|
|
7 |
2 |
p. e87-e88
|
article
|
| 5 |
Alisertib plus induction chemotherapy in previously untreated patients with high-risk, acute myeloid leukaemia: a single-arm, phase 2 trial
|
Brunner, Andrew M
|
|
|
7 |
2 |
p. e122-e133
|
article
|
| 6 |
A resurgence of cord blood transplantation?
|
Eapen, Mary
|
|
|
7 |
2 |
p. e89-e90
|
article
|
| 7 |
Bruton tyrosine-kinase inhibitor on the rise: acalabrutinib in Waldenström macroglobulinemia
|
Buske, Christian
|
|
|
7 |
2 |
p. e85-e86
|
article
|
| 8 |
Caution: PET-CT in plasma cell disorders
|
Lad, Deepesh P
|
|
|
7 |
2 |
p. e95
|
article
|
| 9 |
Childhood cancer: the need to invest in the future
|
The Lancet Haematology,
|
|
|
7 |
2 |
p. e82
|
article
|
| 10 |
Cost considerations in the first-line treatment of advanced Hodgkin lymphoma
|
Perissinotti, Anthony J
|
|
|
7 |
2 |
p. e91-e93
|
article
|
| 11 |
Cost-effectiveness of first-line treatment options for patients with advanced-stage Hodgkin lymphoma: a modelling study
|
Vijenthira, Abi
|
|
|
7 |
2 |
p. e146-e156
|
article
|
| 12 |
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1–2 safety and feasibility study
|
Cohen, Sandra
|
|
|
7 |
2 |
p. e134-e145
|
article
|
| 13 |
Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation
|
Penack, Olaf
|
|
|
7 |
2 |
p. e157-e167
|
article
|
| 14 |
SickleInAfrica
|
Makani, Julie
|
|
|
7 |
2 |
p. e98-e99
|
article
|
| 15 |
The demand and supply of blood in India
|
Mammen, Joy John
|
|
|
7 |
2 |
p. e94
|
article
|
| 16 |
Tumour lysis syndrome in patients with chronic lymphocytic leukaemia treated with BCL-2 inhibitors: risk factors, prophylaxis, and treatment recommendations
|
Tambaro, Francesco Paolo
|
|
|
7 |
2 |
p. e168-e176
|
article
|
| 17 |
What's behind chronic graft versus host disease incidence curves?
|
Mussetti, Alberto
|
|
|
7 |
2 |
p. e83-e84
|
article
|
Journal description